1. Home
  2. CTLT vs BIO Comparison

CTLT vs BIO Comparison

Compare CTLT & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTLT
  • BIO
  • Stock Information
  • Founded
  • CTLT 2007
  • BIO 1952
  • Country
  • CTLT United States
  • BIO United States
  • Employees
  • CTLT N/A
  • BIO N/A
  • Industry
  • CTLT Biotechnology: Pharmaceutical Preparations
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • CTLT Health Care
  • BIO Industrials
  • Exchange
  • CTLT Nasdaq
  • BIO Nasdaq
  • Market Cap
  • CTLT 11.0B
  • BIO 9.5B
  • IPO Year
  • CTLT 2014
  • BIO N/A
  • Fundamental
  • Price
  • CTLT $60.09
  • BIO $343.99
  • Analyst Decision
  • CTLT Hold
  • BIO Strong Buy
  • Analyst Count
  • CTLT 7
  • BIO 4
  • Target Price
  • CTLT $59.83
  • BIO $381.50
  • AVG Volume (30 Days)
  • CTLT 1.6M
  • BIO 468.5K
  • Earning Date
  • CTLT 11-13-2024
  • BIO 10-30-2024
  • Dividend Yield
  • CTLT N/A
  • BIO N/A
  • EPS Growth
  • CTLT N/A
  • BIO N/A
  • EPS
  • CTLT N/A
  • BIO N/A
  • Revenue
  • CTLT $4,381,000,000.00
  • BIO $2,562,604,000.00
  • Revenue This Year
  • CTLT $9.43
  • BIO N/A
  • Revenue Next Year
  • CTLT $8.24
  • BIO $4.49
  • P/E Ratio
  • CTLT N/A
  • BIO N/A
  • Revenue Growth
  • CTLT 2.77
  • BIO N/A
  • 52 Week Low
  • CTLT $31.80
  • BIO $261.59
  • 52 Week High
  • CTLT $61.20
  • BIO $364.24
  • Technical
  • Relative Strength Index (RSI)
  • CTLT 45.94
  • BIO 56.50
  • Support Level
  • CTLT $60.43
  • BIO $329.08
  • Resistance Level
  • CTLT $60.75
  • BIO $346.09
  • Average True Range (ATR)
  • CTLT 0.34
  • BIO 8.23
  • MACD
  • CTLT -0.07
  • BIO -0.23
  • Stochastic Oscillator
  • CTLT 14.15
  • BIO 70.12

About CTLT Catalent Inc.

Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: